Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JURRIAAN M PETERS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology

NPI
1417135385
CMS profile
1058153
Location
BOSTON, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$43,814.75

43 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Neurelis, Inc. $38,535.92 37
Greenwich Biosciences, Inc. $3,178.83 5
Novartis Pharmaceuticals Corporation $2,100.00 1

Page 1 of 1; records 1–43 of 43 matching records. This page contains 43 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JURRIAAN M PETERS

NPI 1417135385 · CMS profile ID 1058153

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology with Special Qualifications in Child Neurology

BOSTON, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–43 of 43 matching records. This page contains 43 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1417135385?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JURRIAAN M PETERS, NPI 1417135385, CMS profile ID 1058153. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–43 of 43 matching records. This page contains 43 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417135385?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). JURRIAAN M PETERS, NPI 1417135385, CMS profile ID 1058153. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–43 of 43 matching records. This page contains 43 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417135385?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
JURRIAAN M PETERS, NPI 1417135385, CMS profile ID 1058153, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–43 of 43 matching records. This page contains 43 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1417135385?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

43 matching records · $43,814.75 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 43 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–43 of 43.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Neurelis, Inc. $1,300.0012/09/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875963 CMS
Neurelis, Inc. $2,895.0012/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875947 CMS
Neurelis, Inc. $31.2112/02/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875951 CMS
Neurelis, Inc. $68.0012/02/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875955 CMS
Neurelis, Inc. $99.9512/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875959 CMS
Neurelis, Inc. $1,300.0011/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875945 CMS
Greenwich Biosciences, Inc. $225.5010/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841838133 CMS
Neurelis, Inc. $3,120.0010/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875917 CMS
Neurelis, Inc. $361.2110/08/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875921 CMS
Neurelis, Inc. $770.9610/08/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875925 CMS
Neurelis, Inc. $358.0010/08/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875929 CMS
Neurelis, Inc. $106.3610/08/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875933 CMS
Neurelis, Inc. $76.0010/08/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875937 CMS
Neurelis, Inc. $124.9910/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875941 CMS
Greenwich Biosciences, Inc. $21.8310/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841838119 CMS
Neurelis, Inc. $98.7809/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875913 CMS
Neurelis, Inc. $1,040.0008/26/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875909 CMS
Neurelis, Inc. $580.0008/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875895 CMS
Neurelis, Inc. $1,740.0008/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875899 CMS
Neurelis, Inc. $1,740.0008/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875901 CMS
Neurelis, Inc. $1,740.0008/10/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875905 CMS
Neurelis, Inc. $1,300.0007/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875891 CMS
Neurelis, Inc. $1,300.0007/21/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875887 CMS
Neurelis, Inc. $580.0007/19/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875871 CMS
Neurelis, Inc. $1,740.0007/19/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875875 CMS
Neurelis, Inc. $580.0007/19/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875879 CMS
Neurelis, Inc. $1,740.0007/19/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875883 CMS
Neurelis, Inc. $2,080.0007/13/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875863 CMS
Neurelis, Inc. $118.2507/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875867 CMS
Neurelis, Inc. $6.1707/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875859 CMS
Neurelis, Inc. $3,120.0006/16/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875851 CMS
Neurelis, Inc. $18.4706/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875855 CMS
Neurelis, Inc. $1,300.0006/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875847 CMS
Greenwich Biosciences, Inc. $225.5005/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841838131 CMS
Neurelis, Inc. $7.5705/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875843 CMS
Neurelis, Inc. $1,350.0003/21/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875839 CMS
Greenwich Biosciences, Inc. $1,353.0003/18/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841838127 CMS
Neurelis, Inc. $1,350.0003/16/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875835 CMS
Neurelis, Inc. $1,350.0003/10/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875831 CMS
Neurelis, Inc. $1,350.0003/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875827 CMS
Neurelis, Inc. $1,695.0002/18/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842875823 CMS
Greenwich Biosciences, Inc. $1,353.0002/02/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841838123 CMS
Novartis Pharmaceuticals Corporation $2,100.0001/28/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813160459 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,827.25 11
PY2020 $50,059.28 39
PY2021 $43,814.75 43
PY2022 $57,017.28 68
PY2023 $40,818.67 49
PY2024 $41,196.66 51
PY2025 $26,999.83 30

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $29,417.25 4
PY2024 Principal investigator $31,149.40 8
PY2023 Principal investigator $53,627.62 15

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Marinus Pharmaceuticals, Inc. $7,853.85 12/15/2023 Non-covered Recipient Entity
BOSTON CHILDRENS HOSPITAL
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028054421
Principal investigator 1 Marinus Pharmaceuticals, Inc. $8,600.00 12/12/2023 Non-covered Recipient Entity
BOSTON CHILDRENS HOSPITAL
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028054269
Principal investigator 1 Marinus Pharmaceuticals, Inc. $2,350.00 10/23/2023 Non-covered Recipient Entity
BOSTON CHILDRENS HOSPITAL
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028053240
Principal investigator 1 Marinus Pharmaceuticals, Inc. $33,050.00 10/23/2023 Non-covered Recipient Entity
BOSTON CHILDRENS HOSPITAL
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028053259
Principal investigator 1 Marinus Pharmaceuticals, Inc. $187.12 04/28/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039395
Principal investigator 1 Marinus Pharmaceuticals, Inc. $97.30 04/28/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039411
Principal investigator 1 Marinus Pharmaceuticals, Inc. $120.67 04/28/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039433
Principal investigator 1 Marinus Pharmaceuticals, Inc. $83.12 04/28/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039451
Principal investigator 1 Marinus Pharmaceuticals, Inc. $22.74 04/28/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039467
Principal investigator 1 Marinus Pharmaceuticals, Inc. $304.07 04/28/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039485
Principal investigator 1 Marinus Pharmaceuticals, Inc. $187.12 04/27/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039313
Principal investigator 1 Marinus Pharmaceuticals, Inc. $125.00 04/27/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039329
Principal investigator 1 Marinus Pharmaceuticals, Inc. $582.57 04/27/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039347
Principal investigator 1 Marinus Pharmaceuticals, Inc. $32.74 04/27/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039363
Principal investigator 1 Marinus Pharmaceuticals, Inc. $31.32 04/27/2023 Covered Recipient Teaching Hospital
CHILDRENS HOSPITAL CORPORATION
A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE) No dispute reported 06/30/2026 1028039379